Gyre Therapeutics (GYRE) Misses Q1 EPS by 3c
Tweet
Share
E-mailGet Alerts GYRE Hot Sheet
Join SI Premium – FREE
Gyre Therapeutics (NASDAQ: GYRE) reported Q1 EPS of $0.00, $0.03 worse than the analyst estimate of $0.03. Revenue for the quarter came in at $22.1 million versus the consensus estimate of $24.5 million.
For earnings history and earnings-related data on Gyre Therapeutics (GYRE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Pizza Hut CEO Aaron Powell resigns
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- GitLab Inc (GTLB) Tops Q2 EPS by 7c, Beats on Revenue
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
